Host Joshua Slatko sits down with IQVIA experts Sarah Rickwood and Natalie Harb to explore the extraordinary growth of the obesity market, what makes it different from other pharma markets, and the evolving patient access landscape. They also discuss the companies positioned for success, future market projections, oral weight-loss medicines, and what the market could look like by 2030.

Listen to part 1: Med Ad Views Episode 09: The modern marvel of the obesity market, an analysis from IQVIA (Part I)

Sarah Rickwood and Natalie Harb explore the obesity pipeline and how continued innovation will shape the market’s future. They discuss how brands will need to differentiate as the market evolves, and how AI and agentic AI could transform communications, HCP and patient engagement, and product launches in the obesity market.

Listen to part 2: Med Ad Views Episode 10: The modern marvel of the obesity market, an analysis from IQVIA (Part 2)